Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
复制标题
DOI：
10.1093/annonc/mdt320
复制
发表时间：
2013-10-01
影响因子：
50.5
通讯作者：
Buske, C.
中科院分区：
文献类型：
--
作者：
Fey, M. F.;Buske, C.
欧洲成人急性髓系白血病(AML)的年发病率为每10万人中有5-8例，70岁以上人群发病率急剧上升，每年发病率达15-25/10万。急性髓系白血病每年的死亡率为每10万人中有4至6例。
The yearly incidence of acute myeloblastic leukaemia (AML) in European adults is five to eight cases per 100 000 individuals with a steep increase in the population aged over 70 years where the incidence reaches 15–25/100 000 per annum. The yearly mortality figure in AML is four to six cases per 100 000.